OPA1 and optic atrophy: This is further supported by the close association of mutations in MFN2 and OPA1 with Charcot–Marie–Tooth disease and optic atrophy, respectively [7, 12–14], while disease as a direct consequence of DRP1 mutation occurs far less frequently [16].